C2I: 9-[(1R,6R,8R,9S,10R,15S,17R,18S)-3,9,12,18-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-17-(6-oxidanylidene-3H-purin-9-yl)-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.3.0.0^{6,10}]octadecan-8-yl]-3H-purin-6-one
C2I is a Ligand Of Interest in 6K6T designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6K6T_C2I_A_501 | 86% | 3% | 0.075 | 0.95 | 4.02 | 2.01 | 21 | 16 | 4 | 0 | 100% | 1 |
| 6K6T_C2I_B_501 | 82% | 3% | 0.079 | 0.94 | 4.06 | 2.02 | 21 | 21 | 0 | 0 | 100% | 1 |
| 6K6T_C2I_C_501 | 81% | 3% | 0.089 | 0.944 | 4.06 | 2.15 | 20 | 21 | 1 | 0 | 100% | 1 |
| 6K6T_C2I_D_501 | 78% | 3% | 0.091 | 0.937 | 4.08 | 1.8 | 25 | 17 | 5 | 0 | 100% | 1 |
